Ebola vaccine trial to start in DR Congo as warning issued over speed of infections

A clinical trial for the Ervebo Ebola vaccine is set to begin in the Democratic Republic of Congo (DR Congo) amidst a rapidly escalating outbreak. The World Health Organization (WHO) reports that approximately half of the 2,500 recorded deaths have occurred in the past 20 days, making this the deadliest outbreak in DR Congo's history and the second-worst globally. The virus, a Bundibugyo species, may have been circulating since February but was initially misdiagnosed. Challenges to the response include difficulties in conflict-affected areas, local distrust, and traditional burial practices. The trial will use 20,000 vaccine doses to assess effectiveness, while 50,000 doses will be given to frontline health workers. The M23 rebel group has also imposed new movement restrictions in North Kivu province.

Congo will receive 70,000 doses of the Ervebo Ebola vaccine to combat the current outbreak, described as the fastest in history. While Ervebo is licensed for Ebola virus, it is not approved for the Bundibugyo virus responsible for this outbreak, though early data suggests it may offer some protection. The World Health Organization and partners announced the allocation, which includes 20,000 doses for a clinical trial to assess its impact on Bundibugyo virus and 50,000 doses for front-line and health workers. The outbreak in eastern Congo has resulted in 2,476 deaths out of 5,208 confirmed cases, spreading significantly faster than previous outbreaks. The lack of approved treatments for Bundibugyo virus and new cases emerging outside monitored populations present major challenges for containment efforts.

The Democratic Republic of Congo (DRC) will receive 70,000 doses of the Ervebo Ebola vaccine to combat its largest outbreak, which has resulted in nearly 2,500 deaths. The World Health Organization (WHO) announced the allocation from the global vaccine stockpile. Of the total doses, 20,000 will be used in a late-stage trial to assess the vaccine's effectiveness against the Bundibugyo virus, responsible for the current outbreak, as Ervebo is not yet licensed for this specific strain. The remaining 50,000 doses are designated for frontline and health workers. Gavi will fund the shipment and vaccination efforts.

The World Health Organization (WHO) head stated that the current Ebola outbreak in eastern Congo is on track to surpass the deadliest outbreak in history, which occurred in West Africa from 2014 to 2016. This outbreak, caused by the rare Bundibugyo virus, has resulted in over 2,000 deaths out of more than 4,300 cases since its declaration on May 15, though it is believed to have started in February. The outbreak is characterized by its rapid spread in a remote, conflict-affected region, outpacing containment efforts. Unlike previous outbreaks, there are no approved vaccines or treatments for the Bundibugyo virus, and many new cases are occurring in communities inaccessible to health workers due to poor infrastructure, ongoing conflict, and misinformation. The WHO anticipates the outbreak's peak in approximately six months, with a possibility of it lasting up to a year.

The Ebola outbreak in the Democratic Republic of the Congo has spread to a sixth province, Bas-Uele, following a death of a man who traveled from Haut-Uele. The World Health Organization head stated the outbreak is on track to be the deadliest in history, potentially surpassing the 2014-16 West Africa outbreak. This current outbreak, caused by the rare Bundibugyo virus, has killed over 2,100 people out of more than 4,500 cases since its declaration on May 15th, though sequencing suggests it began in February. The spread is complicated by unpaid health workers, rebel threats, community anger, and misinformation. Clinical trials for two potential treatments began last month.

The World Health Organization (WHO) stated that the current Ebola outbreak in the Democratic Republic of Congo (DRC) began in February, several months before its official declaration in mid-May. Early cases were misdiagnosed as malaria and typhoid, hindering a timely response. This outbreak, caused by the rare Bundibugyo virus, has spread at an unprecedented rate, with confirmed cases exceeding 4,200 and deaths surpassing 1,900. The WHO's regional director for Africa noted that responders are "chasing the virus" due to these delays. The outbreak is compounded by challenging conditions, including health worker strikes, rebel threats, community distrust, and misinformation, making it the fastest and deadliest on record.

The Democratic Republic of the Congo is experiencing its fastest-growing Ebola outbreak in history, with over 3,360 confirmed cases and 1,487 deaths across five eastern provinces. This outbreak of the Bundibugyo strain, declared on May 15th, is complicated by ongoing conflict in affected areas, hindering health responses. Health officials estimate a 45% case fatality rate and note that new infections continue to rise weekly. While clinical trials for a vaccine began in early July, they could take up to four months. Experts emphasize the need for public cooperation and continued efforts to contain the spread, which was detected late.

The Ebola outbreak in the Democratic Republic of the Congo (DRC) has surpassed 1,500 deaths, with over 3,442 cases recorded. This represents a significant increase in fatalities over the past week, as authorities struggle to contain the virus's spread, particularly in the eastern regions. The outbreak is exacerbated by ongoing conflict, which hinders government control and infrastructure, and the lack of a proven vaccine for the Bundibugyo strain of Ebola. Delays in contact tracing, access challenges, and community mistrust have further complicated response efforts. While mostly concentrated in Ituri province, cases have been confirmed in five other provinces, including Kisangani. Neighboring Uganda has declared its Ebola outbreak over.

The fastest-growing Ebola outbreak in history has killed over 1,500 people in eastern Congo as of Thursday, with cases reaching 3,442. This represents a 50% increase in about a week, indicating response efforts are being outpaced. The outbreak, declared May 15, is caused by the Bundibugyo virus, for which there are no approved vaccines or treatments. Displacement due to conflict and illegal mining, coupled with attacks on health facilities and misinformation, are hindering contact tracing and response efforts, particularly in Ituri province. International partners temporarily withdrew from some areas following an attack, disrupting surveillance and supplies.

The Ebola outbreak in the Democratic Republic of Congo (DRC) has surpassed 1,309 deaths and 2,973 confirmed cases, marking the fastest-spreading Ebola epidemic on record. This surge, a 40% increase in deaths in five days, is attributed to the rare Bundibugyo variant, which currently lacks approved vaccines or treatments. The epidemic is exacerbated by active hostilities and a shortage of public health resources. Scientists are developing an experimental vaccine, with the first dose administered to a volunteer. The outbreak's rapid progression, reaching 1,000 deaths in under 10 weeks, threatens to become the worst in history if not contained. Health workers are striking over unpaid wages and unsafe conditions, further hindering response efforts.